A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer-Reference-Cited by-同舟云学术

A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer

Published:2019-10-03 Issue:3 Volume:371 Page:703-712
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Cheng Jiongjia^ORCID,Moore Stephanie,Gomez-Galeno Jorge,Lee Dong-Hoon,Okolotowicz Karl J.,Cashman John R.^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Hepatic effects assessed by review of safety data in enzalutamide castration-resistant prostate cancer (CRPC) trials;Beer;J Clin Oncol,2018

2. Cashman JR Mercola M Schade D Tsuda M (2013) inventors, Human Biomolecular Research Institute and ChemRegen Inc., assignee. Compounds for inhibition of cancer cell proliferation. U.S. patent 13/748,770. 2016 Aug 2.

3. A Novel Inhibitor Targets Both Wnt Signaling and ATM/p53 in Colorectal Cancer

4. Inhibition of invasive pancreatic cancer: restoring cell apoptosis by activating mitochondrial p53;Cheng;Am J Cancer Res,2019

5. Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity;Journal of Cancer Research and Clinical Oncology;2023-01-31

2. Small molecules vs biologics;New Horizons in Natural Compound Research;2023

3. PPFIA4 promotes castration-resistant prostate cancer by enhancing mitochondrial metabolism through MTHFD2;Journal of Experimental & Clinical Cancer Research;2022-04-05

4. Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer;Biomedicines;2021-08-07

5. Bioanalytical strategies in drug discovery and development;Drug Metabolism Reviews;2021-07-03